Our people are some of the most influential (and vocal) in the region
Mark has more than 30 years of experience as an entrepreneur, investor and corporate advisor in New York, London and Sydney. From 1990 to 2000 Mark was the Australian and Asian representative of Hellman & Friedman following his training on Wall Street with James D. Wolfensohn and in London at Hudson Conway with Lloyd Williams.
In 2000 Mark co-founded leading Australian boutique corporate advisory and private equity firm Carnegie, Wylie & Co Pty Limited with John Wylie. Carnegie Wylie was acquired by leading Wall Street bank, Lazard Inc in 2007, and following the sale, Mark was appointed the CEO of Lazard Australia Private Equity.
Throughout his career, Mark has been involved in a range of diverse Australian and Asian investments and has participated in groups that have acquired major stakes in the Courage Pub Estate, John Fairfax Holdings, Hoyts Cinemas, Formula One Holdings, SCTV, Macquarie Radio Network, Lonely Planet Publications and London Sumatra Plantations. As a corporate advisor, Mark has advised Qantas and Coles Myer on general strategic matters, Westfield on its $22 billion merger and Qantas on its JetStarAsia start-up in Singapore.
Mark holds a BA from Oxford University and a BSc (Hons) from Melbourne University. He is a former Treasurer of the Oxford Union.
US Medtech Partner
Trevor has a broad, global experience with over 25 years in growth-oriented medical technology markets. Trevor’s 25+ year career in medical technology has included roles in product development, marketing, management consulting and venture capital investing. Trevor has been instrumental in working with M. H. Carnegie & Co. to build their healthcare portfolio. He has been directly involved in sourcing, negotiated and managing investments in high-growth medical device companies including Cardiac Dimensions (percutaneous mitral valve repair), Serene Medical (aesthetic medical devices), and Simplify Medical (cervical spinal disc replacement). In 2015 Trevor also served as Interim CEO of Cardiac Dimensions.
Trevor was a General Partner at Frazier Healthcare Ventures, a leading healthcare venture capital and private equity investment firm with over $2.0 billion under management. He co-led the Frazier medical device team and became known as an active and well-regarded investor with particular depth in medical devices. Prior to Frazier Healthcare, Trevor was a Senior Consultant at The Wilkerson Group. Trained as a Biomedical Engineer with an electrical focus, Trevor held product development and product marketing roles at Telectronics Pacing Systems and Ventritex, both in the Cardiac Rhythm Management market.
Trevor serves on the board of the Center for Infectious Disease Research, the largest independent, non-profit research institute in the US focused on vaccines, therapeutics, and diagnostics for diseases of the developing world. He was the board chair from 2012 to 2014. He is also on the board of ElectroCore Medical, Serene Medical, Simplify Medical, and is a board observer at Cardiac Dimensions.
Trevor graduated from the University of Southern Queensland, Australia with a Bachelor of Engineering (Biomedical), and the Massachusetts Institute of Technology with a Masters of Science in Management (Sloan School).
Kate has more than 20 years of experience as a corporate and legal advisor, specialising in mergers and acquisitions. She has worked closely with Mark for over 10 years.
Prior to joining Carnegie, Kate was a Director of Lazard Australia and Senior Legal Counsel and Head of Compliance at Lazard Australia for both private equity and corporate advisory. Kate spent a number of years at law firms Mallesons and Freehills prior to joining Mark at Carnegie Wylie & Co.
In her role at Carnegie, Kate is responsible for managing the relationships amongst the network of contacts that have been created over the years and she has proven time and time again a unique ability to manage complex personalities when the stress of a transaction is at its peak. She is also an active member of the funds’ deal teams where she is heavily involved in transaction negotiation, structuring and execution and has overall responsibility for all legal functions for Carnegie.
Kate is Chairperson of Carsingha Investments (owner of the Entertainment Quarter, Moore Park) and serves on a number of portfolio company boards.
Kate holds a Bachelor of Laws (Hons) from Bond University.
Matthew is a finance and investment professional with over 20 years' experience in acquiring, building and selling businesses across a range of industries, both domestically and internationally.
Matthew has worked on M&A transactions in industries ranging from aviation and property to advertising and marketing. Having been a CEO and CFO Matthew also has extensive experience in growing, developing and managing businesses.
Matthew was the founding CEO of Global Aviation Asset Management (GAAM), an international aircraft leasing business. Matthew grew GAAM from a start-up to a fleet of 53 commercial aircraft, valued at $2bn, and successfully sold the portfolio to the NYSE-listed FLY Leasing Limited in October 2011.
Former experience as an Executive Director at the Liberman Family's LJCB Investment Group, one of Australia's largest family offices.
Matthew has experience in capital markets transactions, preparing businesses for IPO, managing the underwriting of equity capital raisings and preparing bidder's statements for ASX takeovers.
Matthew is a Chartered Accountant and holds a Bachelor of Commerce, majoring in Accounting and Finance, from the University of NSW.
Chair of the Investment Committee
Don is currently Non-Executive Chairman of QIC and an Advisory Council member for FIIG Securities. He is a member of the Managed Investment Schemes Compliance Committee for AMP Capital Funds Management Limited, National Mutual Funds Management Ltd, and ipac Asset Management Limited.
Don was a Non-Executive Director of AMP Capital Investors Limited and AMP Capital Holdings for seven years until March 2014, and an Executive Director of the Community Services Commission for the Anglican Church in South Queensland for four years until August 2011. Prior to this role, Don was CEO of Sunsuper for ten years until May 2007, and prior to that AMP Qld Manager.
Don earned a Bachelor of Science in Maths and Physics and later a Bachelor of Arts majoring in Economics and Psychology from the University of Queensland. He is a Fellow of the Australian Institute of Management and a member of the Australian Institute of Company Directors.
Member of the Investment Committee
Michael was until recently the Founding Chief Executive of Social Ventures Australia, an organisation offering innovative solutions to society’s most pressing social problems. He stepped down as CEO, taking on an Executive Director role in October 2014.
Prior to this role, Michael spent 15 years as a Co-Founder and Executive Director of Macquarie Bank's venture capital arm, Macquarie Direct Investment. In his time there, Michael invested in 42 businesses generating a gross rate of return of 24%.
Michael holds an MBA from Harvard University.
Member of the Investment Committee
Karyn is the Founder and Managing Director of Apostle Funds Management which was established in 2000. Karyn has over 20 years’ experience in funds management, working with companies such as Rothschild Asset Management, ANZ Treasury and Shell. Since founding Apostle Asset Management, Karyn has grown the business significantly with assets raised in excess of $7 billion.
Karyn holds a BA majoring in Business Law and Politics from Macquarie University.